Reuters logo
BRIEF-Quantum Genomics receives FDA clearance of IND application for QGC001 ‍​
September 5, 2017 / 4:12 PM / 15 days ago

BRIEF-Quantum Genomics receives FDA clearance of IND application for QGC001 ‍​

Sept 5 (Reuters) - QUANTUM GENOMICS SA:

* QUANTUM GENOMICS RECEIVES FDA CLEARANCE OF IND APPLICATION FOR QGC001

* COMPANY TO LAUNCH NEW-HOPE, A TARGETED PHASE II CLINICAL TRIAL IN HYPERTENSION IN THE U.S. ‍​‍​

* CLINICAL STUDY TO RECRUIT 250 HYPERTENSIVE AND OVERWEIGHT PATIENTS

* FIRST PATIENT IS EXPECTED TO BE ENROLLED IN Q4 OF 2017

* PRELIMINARY RESULTS ARE EXPECTED IN FIRST HALF OF 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below